STOCK TITAN

Douglas Elliman Inc. Form 4 Filings

DOUG NYSE

Every Form 4 that Douglas Elliman Inc. (DOUG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow DOUG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DOUG filings page.

Rhea-AI Summary

Douglas Elliman Inc. (symbol: DOUG) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Douglas Elliman Inc. (symbol: DOUG) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Brodie Bradley Harris, SVP, General Counsel and Secretary of Douglas Elliman Inc., reported a withholding of 24,593 common shares on August 13, 2026 to satisfy payroll tax liabilities upon vesting of 62,500 restricted stock shares originally awarded on August 13, 2025. The withheld shares were valued at $2.0075 per share, based on the average of the low ($1.95) and high ($2.065) trading prices on the vesting date. Following this tax-withholding disposition, Harris directly holds 400,407 common shares.

Rhea-AI Summary

LAMPEN RICHARD reported acquisition or exercise transactions in this Form 4 filing.

Douglas Elliman Inc. director Richard Lampen received a restricted stock award of 90,910 shares of common stock on April 10, 2026 under the company’s 2021 Management Incentive Plan. The award carries no purchase price and represents equity-based compensation rather than an open-market transaction.

The restricted shares will vest on April 10, 2027, provided Lampen continues in service, with earlier vesting possible upon death, disability, or a change-of-control. Following this grant, he directly holds 1,244,447 shares of common stock. An additional 3,243 shares are held indirectly by his spouse, for which he disclaims beneficial ownership.

Rhea-AI Summary

Weitz Perry reported acquisition or exercise transactions in this Form 4 filing.

Douglas Elliman Inc. director Perry Weitz received a grant of restricted stock. On April 10, 2026, the company awarded him 90,910 shares of common stock under its 2021 Management Incentive Plan at no purchase price. Following this grant, he directly holds 149,504 common shares.

The restricted stock award will vest on April 10, 2027, as long as Weitz continues his service through that date. The award can vest earlier if he dies, becomes disabled, or if a change-of-control of the company occurs.

Rhea-AI Summary

ZEITCHICK MARK reported acquisition or exercise transactions in this Form 4 filing.

Douglas Elliman Inc. director Mark Zeitchick received a grant of 90,910 shares of common stock as a restricted stock award under the company’s 2021 Management Incentive Plan. After this equity award, he holds 388,220 shares directly. The award will fully vest on April 10, 2027, if he continues his service, with earlier vesting possible in the event of death, disability, or a change-of-control.

Rhea-AI Summary

WHITE WILSON reported acquisition or exercise transactions in this Form 4 filing.

Douglas Elliman Inc. director Wilson White received a grant of 90,910 shares of common stock as a restricted stock award under the company’s 2021 Management Incentive Plan. After this equity award, he directly holds 299,290 shares. The restricted shares are compensation, not an open-market purchase.

The award will vest on April 10, 2027, if White continues in service until that date, or earlier if he dies, becomes disabled, or if a change-of-control occurs. Until vesting, the shares remain subject to these conditions, so the economic benefit is realized over time.

Rhea-AI Summary

Brodie Bradley Harris reported acquisition or exercise transactions in this Form 4 filing.

Douglas Elliman Inc. granted its SVP, General Counsel and Secretary, Brodie Bradley Harris, a restricted stock award of 175,000 shares of common stock as equity compensation. The grant was made under the company’s 2021 Management Incentive Plan at no cash cost to Harris.

The award will vest in three equal annual installments starting on December 15, 2026, contingent on his continued employment, with provisions for earlier vesting upon a change-of-control and accelerated vesting of the next tranche if he is terminated without cause or resigns for good reason. Following this grant, Harris directly holds 425,000 shares of Douglas Elliman common stock.

Rhea-AI Summary

KIRKLAND J BRYANT III reported acquisition or exercise transactions in this Form 4 filing.

Douglas Elliman Inc. granted officer KIRKLAND J BRYANT III a restricted stock award of 1,000,000 shares of common stock at no cash cost on April 10, 2026, under the company’s 2021 Management Incentive Plan.

The award will vest in three equal annual installments beginning December 15, 2026, provided he remains employed, with provisions for earlier vesting upon a change-of-control and partial acceleration if his employment ends without cause or for good reason. Following this grant, he directly holds 1,877,274 common shares.

Rhea-AI Summary

Liebowitz Michael reported acquisition or exercise transactions in this Form 4 filing.

Douglas Elliman Inc. President and CEO Michael Liebowitz received a grant of 1,250,000 shares of common stock as a restricted stock award. The award was granted on April 10, 2026 under the company’s 2021 Management Incentive Plan at no cash cost to him.

The restricted stock will vest in three equal annual installments beginning on December 15, 2026, conditioned on his continued employment, with provisions for earlier vesting upon a change-of-control and partial acceleration if he is terminated without cause or leaves for good reason. Following this grant, he holds 2,290,780 shares directly and 1,838,162.149 shares indirectly through MSL18 Holdings LLC, a single‑member LLC he owns, which includes 303,250 shares transferred from his prior direct holdings.

Rhea-AI Summary

Douglas Elliman Inc. reported that a company officer serving as Vice President of Communications had 21,118 shares of common stock withheld on 12/15/2025 to cover payroll tax liabilities arising from the vesting of restricted stock.

The withholding relates to an aggregate 38,750 restricted shares that were awarded on December 31, 2021, March 14, 2023 and February 29, 2024. The withheld shares were valued at $2.755 per share, based on the average of the low $2.66 and high $2.85 stock prices of Douglas Elliman common stock on the vesting date. After this transaction, the officer beneficially owns 91,249 shares of Douglas Elliman common stock directly.

Rhea-AI Summary

Douglas Elliman Inc. reported an insider equity transaction involving its Vice President of Human Resources. On December 15, 2025, 12,876 shares of Douglas Elliman common stock were withheld to pay the executive’s payroll tax liabilities that arose when an aggregate of 25,625 restricted shares vested from awards granted on January 1, 2023 and February 29, 2024. The withheld shares were valued at $2.755 per share, based on the average of the day’s low ($2.66) and high ($2.85) trading prices. After this tax withholding, the executive beneficially owns 70,153 shares of Douglas Elliman common stock, held directly.

Rhea-AI Summary

Douglas Elliman Inc. Executive Vice President, Treasurer and CFO J Bryant Kirkland III reported a tax-related share withholding connected to the vesting of restricted stock.

On December 15, 2025, 75,256 shares of Douglas Elliman common stock were disposed of at $2.755 per share to cover the reporting person’s payroll tax liabilities arising from the vesting of an aggregate 191,250 restricted shares granted on several prior award dates. After this transaction, Kirkland beneficially owned 877,274 shares of Douglas Elliman common stock in direct ownership.

Rhea-AI Summary

Douglas Elliman Inc. reported an equity grant to a director-level insider. On November 26, 2025, the company granted the reporting person a restricted stock award of 58,594 shares of Douglas Elliman common stock under its 2021 Management Incentive Plan. The award was reported as acquired at a price of $0, reflecting that it is a compensatory grant rather than an open-market purchase.

The restricted stock will vest in two equal annual installments on November 26, 2026 and November 26, 2027, as long as the reporting person continues in service through each vesting date. The grant may vest earlier if the reporting person dies, becomes disabled, or if there is a change of control at the company. Following this transaction, the reporting person beneficially owns 58,594 shares of Douglas Elliman common stock directly.

Rhea-AI Summary

Douglas Elliman Inc. (DOUG) President and CEO Michael S. Liebowitz, who is also a director, reported equity changes in a Form 4. On 11/24/2025, 196,750 shares of common stock were withheld at $2.41 per share to cover his payroll tax liabilities tied to the vesting of 500,000 restricted shares originally awarded on November 24, 2024. The $2.41 value reflected the average of that day’s low ($2.35) and high ($2.47) trading prices.

The filing also notes a transfer of 56,530 shares from Liebowitz’s direct holdings to MSL18 Holdings LLC, a single-member LLC he owns. Following these transactions, he beneficially owns 1,344,030 shares directly and 1,534,912.149 shares indirectly through MSL18 Holdings LLC.

Rhea-AI Summary

Douglas Elliman Inc. (DOUG) repurchased its senior secured convertible notes for $95,000,000 on 10/24/2025 from KLCP Fund III (EU) Master AIV LP and KLIM Delta HQC3 LP. The Form 4 reports the disposition of the derivative securities to 0 indirectly held following the transaction. In connection with the repurchase, David Chene resigned from the Board of Directors on 10/24/2025.

The KLCP Fund III note had a principal amount of $45,790,109.01 and the KLIM Delta note had a principal amount of $4,209,890.99, each due on July 2, 2029 with interest at 7.0% in cash or 8.0% paid in kind. The notes were convertible at an initial price of $1.50 per share, subject to a 4.99% Beneficial Ownership Limitation, adjustable on notice up to 24.99%. The table lists underlying common stock amounts of 30,526,740 and 2,806,594 shares for the respective notes.